Using Zepbound, an injectable GLP-1 that costs $450 each month, means Kathryn has not been able to afford to travel like she hoped in retirement
We follow the Obesity Medicine Association Position statement recommendations on Compounded peptides, which recommends that all anti-obesity medications go through clinical testing for safety and efficacy as overseen by the FDA
Beyond the clinical workflows, we built in messaging, community, and coaching spaces to keep patients motivated and supported long term
Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like peptide-1 receptor agonist: a phase 1b, multicentre, blinded, placebo-controlled, randomized, multiple-ascending-dose study in people with type 2 diabetes